290307-40-3 Usage
General Description
5-Bromo-2-(1-hydroxy-1-methylethyl)pyridine is a chemical compound with the molecular formula C7H8BrNO. It is a pyridine derivative with a bromine atom and a hydroxy-1-methylethyl group attached to the second carbon of the pyridine ring. It is commonly used in organic synthesis and pharmaceutical research as a building block for the synthesis of various bioactive compounds. This chemical has also been studied for its potential pharmacological properties, including its anti-inflammatory, antitumor, and antimicrobial activities. Additionally, it is known to be a mild irritant to the eyes and skin and should be handled with care in laboratory settings. Overall, 5-Bromo-2-(1-hydroxy-1-methylethyl)pyridine is a versatile compound with potential applications in both research and industrial settings.
Check Digit Verification of cas no
The CAS Registry Mumber 290307-40-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,9,0,3,0 and 7 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 290307-40:
(8*2)+(7*9)+(6*0)+(5*3)+(4*0)+(3*7)+(2*4)+(1*0)=123
123 % 10 = 3
So 290307-40-3 is a valid CAS Registry Number.
InChI:InChI=1/C8H10BrNO/c1-8(2,11)7-4-3-6(9)5-10-7/h3-5,11H,1-2H3
290307-40-3Relevant articles and documents
COMPOUNDS USEFUL AS CSF1 MODULATORS
-
Paragraph 00493; 00494; 00495, (2016/04/26)
This invention relates to novel compounds and to pharmaceutical compositions comprising the novel compounds. More specifically, the invention relates to compounds useful as Colony Stimulating Factor 1 Receptor (cFMS) modulators (e.g. cFMS inhibitors). This invention also relates to processes for preparing the compounds, uses of the compounds in treatment and methods of treatment employing the compounds. Specifically, the invention relates to the use of the compounds for the treatment of cancer and autoimmune diseases.
CYCLOALKYLNITRILE PYRAZOLE CARBOXAMIDES AS JANUS KINASE INHIBITORS
-
Page/Page column 89-90, (2013/04/10)
Cycloalkylnitrile pyrazole carboxamides as JAK inhibitors useful for the treatment of JAK-mediated diseases such as rheumatoid arthritis, asthma, COPD and cancer are provided.
